Clinical trial supplies teams are under increasing pressure. Pharmaceutical organizations are asking them to do more trials, with greater complexity, more quickly. The approach is shining a light on operations right across the clinical trials supply chain, including labeling and packaging, as pharma sponsors look to increase R&D efficiencies and shorten the time to study start-up. With labeling frequently a bottleneck, many organizations are recognizing the urgent need to strengthen their labeling capabilities.
本書では、製薬会社とその治験サービスパートナーにとって、治験薬・用品のアジャイルなラベリングソリューションがビジネス上不可欠となった理由について考察しています。また、開発期間の短縮、効率性の向上、成長の促進を促すラベリング業務の改善の必要性について、世界的な傾向を検証しています。
Download this paper to discover:
